Aptamer Group (LON:APTA) Shares Up 1.4% – Should You Buy?

Aptamer Group plc (LON:APTAGet Free Report)’s share price rose 1.4% on Thursday . The company traded as high as GBX 0.95 and last traded at GBX 0.91. Approximately 3,148,614 shares were traded during mid-day trading, a decline of 24% from the average daily volume of 4,164,578 shares. The stock had previously closed at GBX 0.90.

Aptamer Group Stock Performance

The firm has a market capitalization of £24.62 million, a PE ratio of -6.52 and a beta of -0.52. The firm’s 50 day moving average price is GBX 0.91 and its 200-day moving average price is GBX 0.81.

About Aptamer Group

(Get Free Report)

Aptamer Group is a leading provider of aptamer selection services and developer of aptamer-based reagents for use in research, bioprocessing, diagnostic, and therapeutic applications. Headquartered in York, UK, the Company partners globally to deliver aptamer-based solutions that drive discovery and development across the life sciences.

Aptamer Group has developed the proprietary Optimer® platform technology that drives three distinct businesses: Aptamer Solutions, Aptamer Diagnostics and Aptamer Therapeutics.

Recommended Stories

Receive News & Ratings for Aptamer Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptamer Group and related companies with MarketBeat.com's FREE daily email newsletter.